C4 Therapeutics, Inc. short interest in 2025
In 2025, C4 Therapeutics, Inc.'s disclosed short interest ran from 13.15% of shares outstanding on 15 Jan 2025 to 7.51% on 31 Dec 2025, a change of -5.64 percentage points. The year's high was 13.15% on 15 Jan 2025 and its low 4.95% on 30 Sep 2025, averaging 8.04% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.84 days on 14 Mar 2025. Full history: C4 Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 13.15% (15 Jan 2025)
- End of year
- 7.51% (31 Dec 2025)
- Change
- -5.64 pp
- High
- 13.15% (15 Jan 2025)
- Low
- 4.95% (30 Sep 2025)
- Average
- 8.04%
- Highest days to cover
- 9.84 (14 Mar 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 13.15% | 4.91 | results (8-K) |
| 31 Jan 2025 | 10.48% | 3.76 | |
| 14 Feb 2025 | 11.42% | 5.00 | |
| 28 Feb 2025 | 12.11% | 4.34 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 11.58% | 9.84 | |
| 31 Mar 2025 | 11.00% | 9.66 | |
| 15 Apr 2025 | 10.95% | 7.05 | |
| 30 Apr 2025 | 9.08% | 4.23 | |
| 15 May 2025 | 8.95% | 6.36 | 10-Q filed, results (8-K) |
| 30 May 2025 | 8.68% | 6.32 | |
| 13 Jun 2025 | 8.98% | 5.72 | |
| 30 Jun 2025 | 6.99% | 3.15 | |
| 15 Jul 2025 | 5.73% | 2.19 | |
| 31 Jul 2025 | 6.54% | 3.66 | |
| 15 Aug 2025 | 5.82% | 2.06 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 5.31% | 3.29 | |
| 15 Sep 2025 | 4.98% | 2.15 | |
| 30 Sep 2025 | 4.95% | 1.86 | |
| 15 Oct 2025 | 5.60% | 1.47 | |
| 31 Oct 2025 | 4.96% | 1.89 | |
| 14 Nov 2025 | 5.00% | 2.92 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 5.77% | 4.84 | |
| 15 Dec 2025 | 7.40% | 4.38 | |
| 31 Dec 2025 | 7.51% | 3.50 |
See also: C4 Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.